首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis of xanthone derivatives and studies on the inhibition against cancer cells growth and synergistic combinations of them
【24h】

Synthesis of xanthone derivatives and studies on the inhibition against cancer cells growth and synergistic combinations of them

机译:X吨酮衍生物的合成与抑制癌细胞生长的抑制作用及其协同组合

获取原文
获取原文并翻译 | 示例
           

摘要

34 Xanthones were synthesized by microwave assisted technique. Their in vitro inhibition activities against five cell lines growth were evaluated. The SAR has been thoroughly discussed. 7-Bromo-1,3-dihydroxy-9H-xanthen-9-one (3-1) was confirmed as the most active agent against MDA-MB-231 cell line growth with an IC50 of 0.46 +/- 0.03 mu M. Combination of 3-1 and 5,6-dimethylxanthone-4-acetic acid (DMXAA) showed the best synergistic effect. Apoptosis analysis indicated different contributions of early/late apoptosis and necrosis to cell death for both monomers and the combination. Western Blot implied that the combination regulated p53/MDM2 to a better healthy state. Furthermore, 3-1 and DMXAA arrested more cells on G2/M phase; while the combination arrested more cells on S phase. All the evidences support that the 3-1/DMXAA combination is a better anti-cancer therapy. (C) 2017 Elsevier Masson SAS. All rights reserved.
机译:通过微波辅助技术合成了34个Xanthones。 他们对五种细胞系生长的体外抑制活性进行了评估。 SAR已经彻底讨论过。 7-溴-1,3-二羟基-9H-xanthen-9-one(3-1)被证实是最活性剂,免受MDA-MB-231细胞系生长的,IC50为0.46 +/- 0.03 mm。 3-1和5,6-二甲基蒽酮-4-乙酸(DMXAA)的组合显示出最佳的协同效应。 细胞凋亡分析表明,早期/晚期细胞凋亡和坏死对两种单体和组合的细胞死亡的不同贡献。 Western Blot暗示该组合调节P53 / MDM2至更好的健康状态。 此外,3-1和DMXAA在G2 / M阶段捕获更多细胞; 虽然组合在S期捕获了更多细胞。 所有证据都支持3-1 / DMXAA组合是一种更好的抗癌治疗。 (c)2017年Elsevier Masson SAS。 版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号